A judge in New Jersey has given the go-ahead for what could be multi-billion dollar litigation surrounding insulin companies and the alleged over-inflated prices charged to consumers.

In court documents released Wednesday, U.S. District Court Judge Brian R. Martinotti established a leadership structure to control and manage the litigation across the entire multi-district litigation (MDL) involving alleged Insulin pricing schemes in the U.S.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]